Desmoid Tumor clinical trials at UCSF
1 research study open to eligible people
Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)
open to eligible people ages 18 years and up
This study evaluates nirogacestat in the treatment of desmoid tumor/aggressive fibromatosis (DT/AF). Half of the participants will receive nirogacestat while the other half will receive placebo.
San Francisco, California and other locations
Last updated: